Uniunea Europeană - română - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - tafasitamab - lymphoma, large b-cell, diffuse - agenți antineoplazici - minjuvi is indicated in combination with lenalidomide followed by minjuvi monotherapy for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) who are not eligible for autologous stem cell transplant (asct).

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

incyte biosciences distribution b.v. - tarile de jos - tafasitamabum - pulb. pt. conc. pt. sol. perf. - 200mg - anticorpi monoclonali

Uniunea Europeană - română - EMA (European Medicines Agency)

janssen-cilag international n.v. - talquetamab - mielom multiplu - agenți antineoplazici - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

janssen biologics b.v. - tarile de jos - talquetamabum - sol. inj. - 2mg/ml - anticorpi monoclonali si conjugati

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

janssen biologics b.v. - tarile de jos - talquetamabum - sol. inj. - 40mg/ml - anticorpi monoclonali si conjugati